Carnitine in treatment of acute cerebral infarction
- VernacularTitle:卡尼汀治疗急性脑梗死
- Author:
Xiu LIN
;
Rong YE
;
Yaoxin WANG
- Publication Type:Journal Article
- From:
Chinese Journal of New Drugs and Clinical Remedies
2001;20(2):121-122
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To study the efficacy and adverse reactions of carnitine on patients with acute cerebral infarction. METHODS: One hundred and thirty-five patients with acute cerebral infarction diagnosed by CT or MRI were randomly divided into 2 groups, on the basis of conventional therapy. Sixty-eight patients in carnitine group (M37,F31; age 60 a± s 17 a) received carnitine 2-3g, iv, drip, qd for 28 d. The other 67 patients of control group (M39, F28; age 63 a±17 a) received compound salvia miltirrhiza 20 mL in dextran-40 glucose injection 500 mL, iv, drip, qd for 28 d. RESULTS: The total effective rates of carnitine group and control group for acute cerebral infarction were 80％ and 55％, respectively (P<0.05). No adverse reactions were found. CONCLUSION: Carnitine is safe and effective in the treatment of acute cerebral infarction.
